Exit Menu

Evaluation and service implementation of molecular diagnostic and minimal residual disease monitoring

Completed

Project description

Evaluation and service implementation of molecular diagnostics and minimal residual disease monitoring is a collaborative project between several UK Universities, led by Guy’s and St. Thomas’ hospitals. The main aim is to estimate the cost-effectiveness of minimal residual disease (MRD) monitoring within the scope of AML17 trial. The evaluation is based on a trial analysis and economic modelling.